Wenna Nie Selected Research

Erianin

1/2023

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenna Nie Research Topics

Disease

7	Neoplasms (Cancer) 08/2023 - 01/2020
3	Esophageal Squamous Cell Carcinoma 04/2023 - 03/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Carcinogenesis 10/2022
1	African Trypanosomiasis (Nagana) 01/2022
1	Adenocarcinoma of Lung 01/2020
1	Infections 10/2013
1	Drug-Related Side Effects and Adverse Reactions 10/2013

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2020
1	Gefitinib (Iressa)FDA Link 08/2023
1	Peptide Elongation Factor 2 (EF-2)IBA 04/2023
1	toosendaninIBA 04/2023
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 04/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	ErianinIBA 01/2023
1	Proto-Oncogene Proteins B-rafIBA 01/2023
1	Long Noncoding RNAIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	3,3'-diindolylmethane (diindolylmethane)IBA 01/2022
1	indoleIBA 01/2022
1	Eflornithine (Ornidyl)FDA Link 01/2022
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 03/2021
1	cirsiliolIBA 03/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020

Therapy/Procedure

1	Therapeutics 10/2013